The Impact of the COVID-19 Pandemic on Exacerbations and Symptoms in Bronchiectasis: A Prospective Study

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

AMER THORACIC SOC

1. Innovative Medicines Initiative
2. European Federation of Pharmaceutical Industries and Associations under the European Commission
3. Inhaled Antibiotic for Bronchiectasis and Cystic Fibrosis [115721]
4. European Respiratory Society through the EMBARC2 (European Multicentre Bronchiectasis Audit and Research Collaboration) consortium
5. United States Bronchiectasis Research Registry/COPD Foundation
6. AstraZeneca
7. Chiesi
8. Grifols
9. Janssen
10. Insmed
11. Novartis
12. Zambon
13. GlaxoSmithKline/British Lung Foundation